Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024-4

Anti-CGRP mAbs for the Preventive Treatment of Migraine: An Overview Review and a Cost Saving Analysis in the Global Scenario

Andrea Zovi, Ruggero Lasala, Francesco Ferrara [...]

Hospital Pharmacy

Open access

Research article

First published 2025

Effectiveness and safety of eptinezumab in anti-CGRP(R) mAbs-naïve and mAbs-non responders’ patients: A retrospective observational study

Alessia Bellotti, Caterina Podella, Paola Sarchielli

Cephalalgia Reports

Open access

Research article

First published 2026-2

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week,prospective multicenter study (the TACHIS study)

Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano [...]

Cephalalgia

Open access

Review article

First published 2023-2

New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy

Mi Ji Lee, Mohammad Al-Mahdi Al-Karagholi, Uwe Reuter

Cephalalgia

Open access

Review article

First published 2025-1

Impact of CGRP monoclonal antibody treatment on blood pressure in patients with migraine: A systematic review and potential clinical implications

Britt W.H. van der Arend, Floor C. van Welie, Michael H. Olsen [...]

Cephalalgia

Free access

Review article

First published 2021-6

Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis

Konstantina Drellia, Lili Kokoti, Christina I Deligianni [...]

Cephalalgia

Open access

Research article

First published 2024

Constipation as a possible predictor of poor treatment response in chronic migraine: A retrospective study of anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibodies and the impact of switching

Sena Uzun, Ulf Frejvall, Per Petersson [...]

Cephalalgia Reports

Open access

Research article

First published 2025

Severe acute allergic reaction after switching anti-calcitonin gene-related peptide monoclonal antibodies: A case report

Ikko Wada, Atsushi Shima, Yuu Tatsuoka [...]

Cephalalgia Reports

Open access

Brief report

First published 2024

Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations

Andrea Burgalassi, Giulia Vigani, Alberto Boccalini [...]

Cephalalgia Reports

Open access

Research article

First published 2024-12

An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine

Marina Romozzi, Ammar Lokhandwala, Catello Vollono [...]

Cephalalgia

Search results